The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)

Christopher C. Dvorak; Elie Haddad; Rebecca H. Buckley; Morton J. Cowan; Brent Logan; Linda M. Griffith; Donald B. Kohn; Sung Yun Pai; Luigi Notarangelo; William Shearer; Susan Prockop; Neena Kapoor; Jennifer Heimall; Sonali Chaudhury; David Shyr; Sharat Chandra; Geoff Cuvelier; Theodore Moore; Shalini Shenoy; Fred Goldman; Angela R. Smith; Gauri Sunkersett; Mark Vander Lugt; Emi Caywood; Troy Quigg; Troy Torgerson; Shanmuganathan Chandrakasan; John Craddock; Blachy J. Dávila Saldaña; Alfred Gillio; Evan Shereck; Victor Aquino; Kenneth DeSantes; Alan Knutsen; Monica Thakar; Lolie Yu; Jennifer M. Puck

doi:10.1016/j.jaci.2018.08.027

The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)

Christopher C. Dvorak, Elie Haddad, Rebecca H. Buckley, Morton J. Cowan, Brent Logan, Linda M. Griffith, Donald B. Kohn, Sung Yun Pai, Luigi Notarangelo, William Shearer, Susan Prockop, Neena Kapoor, Jennifer Heimall, Sonali Chaudhury, David Shyr, Sharat Chandra, Geoff Cuvelier, Theodore Moore, Shalini Shenoy, Fred GoldmanAngela R. Smith, Gauri Sunkersett, Mark Vander Lugt, Emi Caywood, Troy Quigg, Troy Torgerson, Shanmuganathan Chandrakasan, John Craddock, Blachy J. Dávila Saldaña, Alfred Gillio, Evan Shereck, Victor Aquino, Kenneth DeSantes, Alan Knutsen, Monica Thakar, Lolie Yu, Jennifer M. Puck

Pediatric Blood & Marrow Transplant & Cellular Therapy

Research output: Contribution to journal › Article › peer-review

71 Scopus citations

Original language	English (US)
Pages (from-to)	405-407
Number of pages	3
Journal	Journal of Allergy and Clinical Immunology
Volume	143
Issue number	1
DOIs	https://doi.org/10.1016/j.jaci.2018.08.027
State	Published - Jan 2019

Bibliographical note

Funding Information:
This study was supported by the Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases (NIAID), and the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, MD, Public Health Service grant/cooperative agreements U54-AI082973 (PI: M.J.C.), and U54-NS064808 and U01-TR001263 (PI: J.P. Krischer) and R13-AI094943 (PI: M.J.C.), and the Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH. The Primary Immune Deficiency Treatment Consortium (PIDTC) is a part of the Rare Diseases Clinical Research Network of ORDR, NCATS. The collaborative work of the PIDTC with the Pediatric Blood and Marrow Transplant Consortium (PBMTC) is supported by the U54 grants mentioned above along with support from the PBMTC Operations Center by the St Baldrick's Foundation and grant/cooperative agreement U10-HL069254 (PI: M.A. Pulsipher) from both the National Heart, Lung and Blood Institute (NHLBI) and the National Cancer Institute (NCI), NIH. The collaborative work of the PIDTC with the Center for International Blood and Marrow Transplant Research (CIBMTR) is supported by grant/cooperative agreement U24-CA76518 (PI: M.M. Horowitz) from the NCI, the NHLBI, and the NIAID; grant/cooperative agreement U01-HL069294 from the NHLBI; NCI contracts HHSH250201200016C and HHSH234200637015C with the Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services; and grants N00014-13-1-0039 and N00014-14-1-0028 from the Office of Naval Research. The content and opinions expressed are solely the responsibility of the authors and do not represent the official policy or position of the NIAID, ORDR, NCATS, NIH, HRSA, or any other agency of the US government.

Publisher link

10.1016/j.jaci.2018.08.027

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322970

Find It

Find It at U of M Libraries

Cite this

Dvorak, C. C., Haddad, E., Buckley, R. H., Cowan, M. J., Logan, B., Griffith, L. M., Kohn, D. B., Pai, S. Y., Notarangelo, L., Shearer, W., Prockop, S., Kapoor, N., Heimall, J., Chaudhury, S., Shyr, D., Chandra, S., Cuvelier, G., Moore, T., Shenoy, S., ... Puck, J. M. (2019). The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018). Journal of Allergy and Clinical Immunology, 143(1), 405-407. https://doi.org/10.1016/j.jaci.2018.08.027

Dvorak, CC, Haddad, E, Buckley, RH, Cowan, MJ, Logan, B, Griffith, LM, Kohn, DB, Pai, SY, Notarangelo, L, Shearer, W, Prockop, S, Kapoor, N, Heimall, J, Chaudhury, S, Shyr, D, Chandra, S, Cuvelier, G, Moore, T, Shenoy, S, Goldman, F, Smith, AR, Sunkersett, G, Vander Lugt, M, Caywood, E, Quigg, T, Torgerson, T, Chandrakasan, S, Craddock, J, Dávila Saldaña, BJ, Gillio, A, Shereck, E, Aquino, V, DeSantes, K, Knutsen, A, Thakar, M, Yu, L & Puck, JM 2019, 'The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)', Journal of Allergy and Clinical Immunology, vol. 143, no. 1, pp. 405-407. https://doi.org/10.1016/j.jaci.2018.08.027

@article{dd86b1d9328440e897fe672ba04fe2f2,

title = "The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)",

author = "Dvorak, {Christopher C.} and Elie Haddad and Buckley, {Rebecca H.} and Cowan, {Morton J.} and Brent Logan and Griffith, {Linda M.} and Kohn, {Donald B.} and Pai, {Sung Yun} and Luigi Notarangelo and William Shearer and Susan Prockop and Neena Kapoor and Jennifer Heimall and Sonali Chaudhury and David Shyr and Sharat Chandra and Geoff Cuvelier and Theodore Moore and Shalini Shenoy and Fred Goldman and Smith, {Angela R.} and Gauri Sunkersett and {Vander Lugt}, Mark and Emi Caywood and Troy Quigg and Troy Torgerson and Shanmuganathan Chandrakasan and John Craddock and {D{\'a}vila Salda{\~n}a}, {Blachy J.} and Alfred Gillio and Evan Shereck and Victor Aquino and Kenneth DeSantes and Alan Knutsen and Monica Thakar and Lolie Yu and Puck, {Jennifer M.}",

note = "Funding Information: This study was supported by the Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases (NIAID), and the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, MD, Public Health Service grant/cooperative agreements U54-AI082973 (PI: M.J.C.), and U54-NS064808 and U01-TR001263 (PI: J.P. Krischer) and R13-AI094943 (PI: M.J.C.), and the Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH. The Primary Immune Deficiency Treatment Consortium (PIDTC) is a part of the Rare Diseases Clinical Research Network of ORDR, NCATS. The collaborative work of the PIDTC with the Pediatric Blood and Marrow Transplant Consortium (PBMTC) is supported by the U54 grants mentioned above along with support from the PBMTC Operations Center by the St Baldrick's Foundation and grant/cooperative agreement U10-HL069254 (PI: M.A. Pulsipher) from both the National Heart, Lung and Blood Institute (NHLBI) and the National Cancer Institute (NCI), NIH. The collaborative work of the PIDTC with the Center for International Blood and Marrow Transplant Research (CIBMTR) is supported by grant/cooperative agreement U24-CA76518 (PI: M.M. Horowitz) from the NCI, the NHLBI, and the NIAID; grant/cooperative agreement U01-HL069294 from the NHLBI; NCI contracts HHSH250201200016C and HHSH234200637015C with the Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services; and grants N00014-13-1-0039 and N00014-14-1-0028 from the Office of Naval Research. The content and opinions expressed are solely the responsibility of the authors and do not represent the official policy or position of the NIAID, ORDR, NCATS, NIH, HRSA, or any other agency of the US government.",

year = "2019",

month = jan,

doi = "10.1016/j.jaci.2018.08.027",

language = "English (US)",

volume = "143",

pages = "405--407",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)

AU - Dvorak, Christopher C.

AU - Haddad, Elie

AU - Buckley, Rebecca H.

AU - Cowan, Morton J.

AU - Logan, Brent

AU - Griffith, Linda M.

AU - Kohn, Donald B.

AU - Pai, Sung Yun

AU - Notarangelo, Luigi

AU - Shearer, William

AU - Prockop, Susan

AU - Kapoor, Neena

AU - Heimall, Jennifer

AU - Chaudhury, Sonali

AU - Shyr, David

AU - Chandra, Sharat

AU - Cuvelier, Geoff

AU - Moore, Theodore

AU - Shenoy, Shalini

AU - Goldman, Fred

AU - Smith, Angela R.

AU - Sunkersett, Gauri

AU - Vander Lugt, Mark

AU - Caywood, Emi

AU - Quigg, Troy

AU - Torgerson, Troy

AU - Chandrakasan, Shanmuganathan

AU - Craddock, John

AU - Dávila Saldaña, Blachy J.

AU - Gillio, Alfred

AU - Shereck, Evan

AU - Aquino, Victor

AU - DeSantes, Kenneth

AU - Knutsen, Alan

AU - Thakar, Monica

AU - Yu, Lolie

AU - Puck, Jennifer M.

N1 - Funding Information: This study was supported by the Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases (NIAID), and the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, MD, Public Health Service grant/cooperative agreements U54-AI082973 (PI: M.J.C.), and U54-NS064808 and U01-TR001263 (PI: J.P. Krischer) and R13-AI094943 (PI: M.J.C.), and the Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH. The Primary Immune Deficiency Treatment Consortium (PIDTC) is a part of the Rare Diseases Clinical Research Network of ORDR, NCATS. The collaborative work of the PIDTC with the Pediatric Blood and Marrow Transplant Consortium (PBMTC) is supported by the U54 grants mentioned above along with support from the PBMTC Operations Center by the St Baldrick's Foundation and grant/cooperative agreement U10-HL069254 (PI: M.A. Pulsipher) from both the National Heart, Lung and Blood Institute (NHLBI) and the National Cancer Institute (NCI), NIH. The collaborative work of the PIDTC with the Center for International Blood and Marrow Transplant Research (CIBMTR) is supported by grant/cooperative agreement U24-CA76518 (PI: M.M. Horowitz) from the NCI, the NHLBI, and the NIAID; grant/cooperative agreement U01-HL069294 from the NHLBI; NCI contracts HHSH250201200016C and HHSH234200637015C with the Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services; and grants N00014-13-1-0039 and N00014-14-1-0028 from the Office of Naval Research. The content and opinions expressed are solely the responsibility of the authors and do not represent the official policy or position of the NIAID, ORDR, NCATS, NIH, HRSA, or any other agency of the US government.

PY - 2019/1

Y1 - 2019/1

UR - http://www.scopus.com/inward/record.url?scp=85054131174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054131174&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2018.08.027

DO - 10.1016/j.jaci.2018.08.027

M3 - Article

C2 - 30193840

AN - SCOPUS:85054131174

SN - 0091-6749

VL - 143

SP - 405

EP - 407

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 1

ER -

The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)

Bibliographical note

Publisher link

Find It

Other files and links

Cite this